Tresiba (insulin degludec)

pCPA File Number: 21002
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 1 & 2
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CDA-AMC Project Number:
SR0521-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: